ViaCord | From Revvity


What's New in Cord Blood and Genomics

Whether it's a new research finding, an educational resource, or a patient story, we're always looking for opportunities to help support informed decision-making. Here are a few highlights.

 
Medical Advances

Clinical Advances
Newborn Screening Enables Early Cord Blood Transplantation for Rare Genetic Disorders

A recent study published in JAMA Network Open highlights the powerful impact of early detection in neonatal care. Researchers reported successful, presymptomatic cord blood transplantation and advanced enzyme therapies in infants diagnosed with Mucopolysaccharidosis via newborn screening. The findings reinforce how early detection can dramatically alter clinical outcomes before symptoms even appear.
Read the Full Study
Family Stories

Family Stories
A ViaCord Family's Journey with Diamond-Blackfan Anemia

Drawing on her experience as a pediatrician and heeding the recommendation of her colleague, a pediatric hematologist-oncologist, Kathy banked her eldest son's cord blood with ViaCord, never imagining she'd need it. When her second son, Luke, was born with an unexpected diagnosis of Diamond Blackfan Anemia, Andrew’s preserved cord blood provided a potentially life-saving transplant. Today, Luke is thriving and living proof of cord blood banking's remarkable potential.
Watch Luke's Story
Industry Insights

Genomics Spotlight 
The Value of Rapid Genomic Testing in Critically Ill Newborns

How valuable is a genetic test when it doesn't change treatment? As genomic testing becomes more common in neonatal care, researchers are taking a closer look at its impact on clinical decision-making, prognostic understanding, and family experiences. A recent JAMA study offers new insights into how both clinicians and parents perceive its value.
Explore the Research
Inside ViaCord

Inside ViaCord
What Happens After Cord Blood Collection?

Ever wonder what happens after a collection kit leaves the delivery room? Take a behind-the-scenes look inside ViaCord's laboratory and follow the journey of newborn stem cells from kit arrival through processing, quality testing, and cryogenic storage.
Watch the Lab Tour
ViaCord | From Revvity
X Facebook YouTube Instagram LinkedIn
FDA REGISTERED Clinical Laboratory Improvement Amendments
Association for the Advancement of Blood & Biotherapies BBB Accredited Business
Disclaimer: Banking cord blood does not ensure that treatment will work, and only a doctor can determine when it can be used. This is intended for educational purposes only and should not be used or interpreted as information on treatments or diagnoses. Cord tissue stem cells have not been used in treatment yet. Research is ongoing. The content shall not be used to make a diagnosis or to replace or overrule a health care provider’s judgement. Always consult with a qualified and licensed physician or other medical care provider.
Privacy Policy

ViaCord 77 4th Ave Waltham, MA, 02451, United States